Delivery Order SPE2DR25D1110-SPE2DR26F13MF
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Glimepiride 4 mg tablets in a quantity of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,126.05 under firm fixed price terms, with an ultimate completion date of September 9, 2025. The delivery order was issued on September 8, 2025, and will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,846.39 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in a quantity of 100 units. This competitive award, issued on December 1, 2025, with an ultimate completion date of December 2, 2025, represents a firm fixed-price transaction with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count) on November 10, 2025, with a ceiling value of $5,312.64 and an ultimate completion date of November 12, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $9,201.03 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by November 4, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Glimepiride 4 mg tablets (100 count) with a ceiling value of $2,377.11. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is set for ultimate completion by July 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100, with a contract value of $9,136.01 and a completion date of September 18, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded under competitive procedures. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order valued at $2,174.34 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count packaging) under a firm fixed-price contract. The award, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,157.52 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100 count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,210.66 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 MG tablets (100-count units) under a firm fixed-price contract. The award was made on December 3, 2025, with an ultimate completion date of December 4, 2025, and does not utilize a set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task under...
- The Defense Logistics Agency awarded a $5,207.80 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100. The contract, with an ultimate completion date of May 28, 2025, represents a competitively awarded, non-set-aside procurement with performance location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DR25D1110Indefinite Delivery Contract
- SPE2DR25D1110-SPE2DR26F13MFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units under a firm fixed-price contract valued at $1,411.27. The order, issued on January 5, 2026, with an ultimate completion date of January 6, 2026, represents a non-competitive delivery order executed under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location in Conshohocken, PA. This delivery order is executed as a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a global pharmaceutical support vehicle enabling the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp was selected through competitive procurement processes and maintains the capability to fulfill federal medical supply requirements across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/4/26 |